Cargando…

L-63 Anticoagulation des patients COVID : risque hémorragique et thrombotique

Detalles Bibliográficos
Autor principal: Tacquard, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642868/
http://dx.doi.org/10.1016/j.tracli.2022.09.059
_version_ 1784826402437070848
author Tacquard, Charles
author_facet Tacquard, Charles
author_sort Tacquard, Charles
collection PubMed
description
format Online
Article
Text
id pubmed-9642868
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-96428682022-11-14 L-63 Anticoagulation des patients COVID : risque hémorragique et thrombotique Tacquard, Charles Transfus Clin Biol Article Elsevier Science 2022-11 2022-11-08 /pmc/articles/PMC9642868/ http://dx.doi.org/10.1016/j.tracli.2022.09.059 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Tacquard, Charles
L-63 Anticoagulation des patients COVID : risque hémorragique et thrombotique
title L-63 Anticoagulation des patients COVID : risque hémorragique et thrombotique
title_full L-63 Anticoagulation des patients COVID : risque hémorragique et thrombotique
title_fullStr L-63 Anticoagulation des patients COVID : risque hémorragique et thrombotique
title_full_unstemmed L-63 Anticoagulation des patients COVID : risque hémorragique et thrombotique
title_short L-63 Anticoagulation des patients COVID : risque hémorragique et thrombotique
title_sort l-63 anticoagulation des patients covid : risque hémorragique et thrombotique
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642868/
http://dx.doi.org/10.1016/j.tracli.2022.09.059
work_keys_str_mv AT tacquardcharles l63anticoagulationdespatientscovidrisquehemorragiqueetthrombotique